Inspire Veterinary Partners, Inc. (IVP) 股票分析

公司概述

Inspire Veterinary Partners, Inc. owns and operates a network of veterinary hospitals across the United States, specializing in small animal general practice hospitals that serve companion pets, canine, and feline breeds, while also extending services to equine care and providing surgical procedures including soft tissue surgery. The company operates within the Consumer Cyclical sector, specifically classified under the Personal Services industry, a positioning that aligns its performance with broader discretionary spending trends and consumer demand for pet healthcare. As of the latest available data, the firm demonstrates a market capitalization of $4.05 million and employs 113 individuals to support its operational footprint. The combination of a $4.05 million market cap and $15.56 million in annual revenue indicates a small-cap enterprise with a revenue base significantly larger than its equity valuation, suggesting the market prices the stock primarily on potential future earnings or asset backing rather than current profit generation.

财务健康

The company reported a trailing twelve-month revenue of $15.56 million, yet it recorded a net income of -$11,942,600 and an EBITDA of -$7,723,924, revealing a substantial gap where operating expenses and costs of goods sold far exceed gross revenue generation. This wide disparity between the $15.56 million revenue and the negative net income highlights a highly leveraged cost structure where fixed costs or specific operational expenditures are consuming the majority of top-line income before reaching the bottom line. Free cash flow stands at -$129,976, indicating that the company is currently burning cash, which limits its financial flexibility to fund internal growth projects or weather economic downturns without external financing. The gross margin is calculated at 19.4%, while the operating margin is negative at -45.6% and the profit margin is even more severe at -76.8%, collectively showing that for every dollar of revenue, the company retains very little value before taxes and loses a significant portion after all operational expenses. On the balance sheet, Inspire Veterinary Partners holds $2.91 million in cash against $17.12 million in debt, resulting in a debt-to-equity ratio of 410.61%, which signifies an extremely leveraged position where debt obligations are more than four times the equity base. The current ratio is 0.39, meaning current assets are less than half of current liabilities, indicating a severe short-term liquidity constraint where the company struggles to meet its obligations due within the next year. Return on Equity is a staggering -331.8% and Return on Assets is -24.0%, metrics that reveal management is currently destroying shareholder value and utilizing assets inefficiently to generate positive returns.

估值评估

Trailing twelve-month P/E and forward P/E ratios are listed as N/A due to the negative earnings, implying that traditional earnings-based valuation models cannot be applied and that the market is not pricing in a near-term earnings trajectory based on historical profitability. The price-to-book ratio is 0.05, indicating that the stock is trading at only 5% of its book value, which suggests the market assigns a negligible premium or even a significant discount to the company's net tangible assets. Price-to-sales ratio stands at 0.26 and EV/EBITDA is -1.87; these alternative valuation metrics suggest the company is valued at a fraction of its sales revenue, reflecting high risk or potential undervaluation contingent on a turnaround in profitability. The 52-week high is $3.32 and the 52-week low is $0.01; without a specific current price provided in the source facts, the valuation context relies on these extreme bounds to illustrate the volatility of the security, noting that the price-to-book of 0.05 represents a significant deviation from standard market multiples. The beta is -0.45, a unique and negative figure that implies the stock's price volatility moves inversely to the broader market or is decoupled from standard market movements, presenting a non-linear risk profile for portfolio diversification.

Growth & Income

Revenue growth year-over-year is 6.6%, while earnings growth is N/A due to the negative net income, indicating that the company is generating top-line expansion but failing to translate this volume into profitability, suggesting that growth is currently offset by rising costs or insufficient pricing power. The dividend yield and payout ratio are both N/A and 0.0% respectively, confirming that the company is not a dividend payer and does not distribute any cash to shareholders. Given the negative net income and zero payout ratio, the company is clearly in a reinvestment phase where it must retain all earnings to cover debt service and operational deficits rather than paying dividends. The overall growth and income profile is characterized by modest top-line expansion coupled with significant structural losses and no current income distribution, positioning the firm as a high-risk, non-income-generating asset reliant on future operational improvements to restore profitability.